Much research supports a remarkable activity for DMAMCL to glioma, including biodistribution of DMAMCL, potential to inhibit the growth of glioma cells, and probable mechanisms of targeting Bcl-2 signal pathway. The gene discussed is BCL2; the disease is central nervous system cancer.